Supplementary Figure 6 from Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors

Kyle Brandon Williams; Alex T. Larsson; Bryant J. Keller; Katherine E. Chaney; Rory L. Williams; Minu M. Bhunia; Garrett M. Draper; Tyler A. Jubenville; Wendy A. Hudson; Gunda I. Georg; Christopher L. Moertel; Nancy Ratner; David A. Largaespada

doi:10.1158/1535-7163.31248662

Supplementary Figure 6 from Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors

2026 Open access

Read full text

Authors: Kyle Brandon Williams, Alex T. Larsson, Bryant J. Keller, Katherine E. Chaney, Rory L. Williams, Minu M. Bhunia, Garrett M. Draper, Tyler A. Jubenville, Wendy A. Hudson, Gunda I. Georg, Christopher L. Moertel, Nancy Ratner

+1 more

David A. Largaespada

DOI: 10.1158/1535-7163.31248662

Cited by: 0

Abstract

Supplementary Figure 6 shows the effects of combination drug therapy on NF1 -/- vs NF1 ± human Schwann cell lines.

Fields of Study & Subjects

Neurofibromatosis and Schwannoma Cases Chromatin Remodeling and Cancer Protein Tyrosine Phosphatases

Publication details

Publication date: 4 February 2026